Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1984 Aug;47(8):844-7.
doi: 10.1136/jnnp.47.8.844.

A double blind trial of sulpiride in Huntington's disease and tardive dyskinesia

N Quinn, C D Marsden
Clinical Trial

A double blind trial of sulpiride in Huntington's disease and tardive dyskinesia

N Quinn et al. J Neurol Neurosurg Psychiatry. 1984 Aug.

Abstract

Eleven patients with Huntington's disease and nine patients with tardive dyskinesia participated in a randomised double-blind crossover trial of sulpiride (as sole antidopaminergic therapy) versus placebo. Although functional improvement was not seen in Huntington's disease patients, sulpiride reduced movement count and total dyskinesia score in both conditions. Sulpiride differs pharmacologically in several respects from conventional neuroleptics, and has not been convincingly shown to cause tardive dyskinesia. Among currently available treatments, it may therefore be considered a drug of choice for treatment of tardive dyskinesia.

PubMed Disclaimer

References

    1. Br Med J. 1978 Jan 14;1(6105):77-8 - PubMed
    1. Nature. 1979 Jan 11;277(5692):93-6 - PubMed
    1. Neurology. 1979 Jan;29(1):1-3 - PubMed
    1. Psychopharmacology (Berl). 1979;66(1):73-7 - PubMed
    1. Arch Neurol. 1982 Aug;39(8):494-6 - PubMed

Publication types